Joint statement: The polluter-pays principle should remain at the core of the Union’s wastewater treatment legislation
A large group of stakeholders representing drinking and wastewater service providers, local public utilities, local and regional governments, environmental civil society organisations and water-related innovation industries unite their voice to support the financing mechanism proposed by the European Commission to ensure a fair and equitable distribution of the costs involved in removing micro-pollutants from wastewater in the proposed revision of the Urban Wastewater Treatment Directive (UWWTD).
On 26 October 2022, the European Commission adopted a
In its proposal, the Commission makes selected sectors contribute to the costs of upgrading wastewater treatment plants to treat harmful pollutants that are released from the use of their products based on the Extended Producer Responsibility (EPR) principle. The scheme focuses on the pharmaceuticals and the cosmetics sectors, which are
The undersigned organisations strongly welcome this proposal to make producers contribute to the cost of removing substances harmful for the environment from wastewater and jointly stress the crucial need to maintain the EPR scheme in the final text negotiated between the European Parliament and the Council. The scheme is a powerful mechanism that allows for a fair distribution of wastewater treatment costs between polluting sectors and urban water users and mitigates the impact of the Directive on water affordability for households in the midst of a cost-of-living crisis.
The EPR scheme is based on the polluter-pays principle, which is the cornerstone of the Union’s environmental policy as per Article 191(2) of the 2007 Treaty on the Functioning of the EU. A
There is compelling evidence on the existence of micro-pollutants from pharmaceutical and cosmetic products in wastewater and it is possible to track pharmaceutical and cosmetic residues in wastewater to specific products through water-smart tools.
According to the Commission, the
EPR schemes for collecting and treating solid waste stemming from the use of pharmaceuticals are already in place in several Member States with
The EPR scheme could also act as an incentive for pharmaceutical and cosmetics industries based in the EU to develop ‘greener’ molecules, which would give them a competitive edge over competitors in third countries, and reduce pollution at source in line with the European Green Deal.
Last but not least, the implementation of an EU-wide EPR scheme is also a matter of internal market functioning, as it creates a level playing field for the industry across the EU, thereby reducing the risk of environmental dumping.
As a conclusion, the EPR scheme is an environmentally effective, economically efficient, and socially fair financing instrument to address the treatment of micro-pollutants in wastewater and avoid their discharge into receiving water bodies for the benefit of our health and the one of our ecosystems.
The undersigned organisations call on all policymakers at European and national level to safeguard this approach in the Commission’s proposal to ensure a fair transition towards a more sustainable, toxic-free Europe.
Aqua Publica Europea
Council of European Municipalities and Regions (CEMR)
European Anglers Alliance
European Environmental Bureau (EEB)
Health Care Without Harm (HCWH) Europe
- Created on .